Willkommen, schön sind Sie da!
Logo Ex Libris

Systems Biology in Biotech & Pharma

  • E-Book (pdf)
  • 127 Seiten
(0) Erste Bewertung abgeben
Alle Bewertungen ansehen
The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as... Weiterlesen
CHF 65.90
Download steht sofort bereit
Informationen zu E-Books
E-Books eignen sich auch für mobile Geräte (sehen Sie dazu die Anleitungen).
E-Books von Ex Libris sind mit Adobe DRM kopiergeschützt: Erfahren Sie mehr.
Weitere Informationen finden Sie hier.
Bestellung & Lieferung in eine Filiale möglich


The US is currently well ahead of the rest of the world in the development and application of SB and its principles especially as they pertain to basic medical research and development. This lead is largely due to its earlier start in the academic arena. However, there is evidence of rapid development in both the UK/EU and Japan, and the gap is narrowing, particularly in the UK. From an industrial point of view, the Pharmaceutical Industry based in the US and UK can capitalize on these opportunities and gain the benefits of this technology. Many educational institutions (particularly their medical divisions) at present are heavily business-oriented, realize that in this particular industrial environment, that every dollar counts.


Abstract.- 1 Introduction: Discovery & Development - New Facet Of Industry, New Tools And Lead Optimization: 1.1 Scope And Content Of This Review.- 1.2 Drug Discovery & Development.- 1.3 Defining Sb: Key Components.- 1.4 A Brief History Of Systems Biology (Sb), In Terms Of Key Advances.- 1.5 Perspective And Potential Impact Of Systems Biology On Academic Funding And Pharma R&D & Cost Savings.- 2 Discovery: Use Of Systems Biology For Identifying Targets: 2.1 Identifying Targets & Druggability Space.- 2.2 Combinatorial Chemistry Tools.- 2.3 Summarizing.- 3 Integrative Systems Biology I - Biochemistry: Phase I Lead Discovery & Molecular Interactions.- 3.1 Molecular Screens: Receptor-Ligand (R-L) Interaction & Molecular Modeling.- 3.2 Collateral Efficacy & Permissive Antagonism.- 3.3 Co-Drugging: Multiple Targets, Combination Therapy & Multistage Targeting.- 3.4 Text Mining For Interactions.- 3.5 Employment Of Biochemical Networks.- 3.6 Overview Of Deterministic Models.- 3.7 Bioinformatics.- 3.8 Summarizing.- 4 Integrative Systems Biology Ii - Molecular Biology: Phase 2 Lead Discovery & In Silico Screening.- 4.1 Omics.- 4.2 Chemogenomics.- 4.3 Morphogenics.- 4.4 Minimal Phenotype & Synthetic Biology.- 4.5 Reconstructing Biological Networks.- 4.6 Summarizing.- 5. Discovery: Computational Systems Biology (Csb) In Health & And Disease I.- 5.1 Cellular Environment: Network Reconstruction & Inference From Experimental Data.- 5.2 Reconstructing Gene Networks.- 5.3 Data Mining And Heuristic Data Preprocessing Tools.- 5.4 Analysis Of Disease 'Correlation Networktm' And Concerted Metabolic Activation - Disease As A Systems Network Property.- 5.5 Challenges For Stem Cells: Control.- 5.6 Emergent Properties.- 5.7 Computational Systems Biology.- 5.8 Summarizing.- 6 Development: In Vivo Pharmacology - Systems Biology In Health & Disease Ii.- 6.1 Animal Disease Models.- 6.2 Pheno- And Genotyping.- 6.3 Rna Interference.- 6.4 Pharmacogenomics (Pgn).- 6.5 In Silico Pharmacology: Future.- 6.6 Summarizing.- 7 Development: Pharmacokinetics - Systems Biology In Health & Disease Iii.- 7.1 Microdosing In Pk.- 7.2 Adaptive Trial Design.- 7.3 Equilibrium Vs. Non-Equilibrium Pk Models.- 7.5 Toxicity Biomarkers.- 7.6 In Silico Toxicity Prediction.- 7.7 Quantitative Pkpd/Tox Modeling.- 7.8 Summarizing.- 8 Development: Multiscale Csb - Simulation Tools.- 8.1 Defining Csb.- 8.2 Redefining (& Discovering) Emergent Properties At Higher-Level Hierarchies.- 8.3 Virtual Organs, Disease Models, Virtual Patient.- 8.4 Population Level Model: Towards Individualized Medicine.- 8.5 Targeting Networks: Towards Organismic, Full-Scale Design.- 8.6 Redefining The Traditional R&D Paradigm.- 8.7 Summarizing.- 9 Development: Drug Formulation & Delivery.- 9.1 Targeting Concept & Mechanisms.- 9.2 Nanoscale Drug Delivery Systems.- 9.3 Csb At Formulation & Delivery.- 9.4 Summarizing.- 10 Development: Preclinical Model Based Drug Development.- 10.1 Defining Mbdd.- 10.2 Summarizing.- 11 Systems Biology: Impact On Pharma And Biotech.- 11.1 Sb Impact.- 11.2 Key Technologies And Tools Needed For Development Of Systems Biology/Csb.- 11.3 Steps In Systems Biology/Csb.- 11.4 Benefits Of Systems Biology And Csb.- 11.5 Summary.- 12 Acknowledgment.- 13 Bibliography


Titel: Systems Biology in Biotech & Pharma
Untertitel: A Changing Paradigm
EAN: 9789400728493
ISBN: 978-94-007-2849-3
Format: E-Book (pdf)
Hersteller: Springer Netherlands
Herausgeber: Springer
Genre: Medizin
Veröffentlichung: 05.01.2012
Digitaler Kopierschutz: Wasserzeichen
Dateigrösse: 3.71 MB
Anzahl Seiten: 127
Jahr: 2012